Therefore, AQP2 impairment is an important cause of water retention that exacerbates the prognosis of congestive heart failure, which is now attracting considerable attention as a novel therapeutic target for water balance disorders which commonly occur in CHF. This evidence concerns the gene AQP2 and congestive heart failure.